Cargando…
Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2, a new member of the genus Betacoronavirus, is a pandemic virus, which has caused numerous fatalities, particularly in the elderly and persons with underlying morbidities. At present, there are no approved vaccines nor antiviral therap...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563800/ https://www.ncbi.nlm.nih.gov/pubmed/32679691 http://dx.doi.org/10.3390/vaccines8030386 |
_version_ | 1783595568995500032 |
---|---|
author | Zettl, Ferdinand Meister, Toni Luise Vollmer, Tanja Fischer, Bastian Steinmann, Jörg Krawczyk, Adalbert V’kovski, Philip Todt, Daniel Steinmann, Eike Pfaender, Stephanie Zimmer, Gert |
author_facet | Zettl, Ferdinand Meister, Toni Luise Vollmer, Tanja Fischer, Bastian Steinmann, Jörg Krawczyk, Adalbert V’kovski, Philip Todt, Daniel Steinmann, Eike Pfaender, Stephanie Zimmer, Gert |
author_sort | Zettl, Ferdinand |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2, a new member of the genus Betacoronavirus, is a pandemic virus, which has caused numerous fatalities, particularly in the elderly and persons with underlying morbidities. At present, there are no approved vaccines nor antiviral therapies available. The detection and quantification of SARS-CoV-2-neutralizing antibodies plays a crucial role in the assessment of the immune status of convalescent COVID-19 patients, evaluation of recombinant therapeutic antibodies, and the evaluation of novel vaccines. To detect SARS-CoV-2-neutralizing antibodies, classically, a virus-neutralization test has to be performed at biosafety level 3, considerably limiting the general use of this test. In the present work, a biosafety level 1 pseudotype virus assay based on a propagation-incompetent vesicular stomatitis virus (VSV) has been used to determine the neutralizing antibody titers in convalescent COVID-19 patients. The neutralization titers in serum of two independently analyzed patient cohorts were available within 18 h and correlated well with those obtained with a classical SARS-CoV-2 neutralization test (Pearson correlation coefficients of r = 0.929 and r = 0.939, respectively). Most convalescent COVID-19 patients had only low titers of neutralizing antibodies (ND50 < 320). The sera of convalescent COVID-19 patients also neutralized pseudotype virus displaying the SARS-CoV-1 spike protein on their surface, which is homologous to the SARS-CoV-2 spike protein. In summary, we report a robust virus-neutralization assay, which can be used at low biosafety level 1 to rapidly quantify SARS-CoV-2-neutralizing antibodies in convalescent COVID-19 patients and vaccinated individuals. |
format | Online Article Text |
id | pubmed-7563800 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75638002020-10-27 Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes Zettl, Ferdinand Meister, Toni Luise Vollmer, Tanja Fischer, Bastian Steinmann, Jörg Krawczyk, Adalbert V’kovski, Philip Todt, Daniel Steinmann, Eike Pfaender, Stephanie Zimmer, Gert Vaccines (Basel) Article Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2, a new member of the genus Betacoronavirus, is a pandemic virus, which has caused numerous fatalities, particularly in the elderly and persons with underlying morbidities. At present, there are no approved vaccines nor antiviral therapies available. The detection and quantification of SARS-CoV-2-neutralizing antibodies plays a crucial role in the assessment of the immune status of convalescent COVID-19 patients, evaluation of recombinant therapeutic antibodies, and the evaluation of novel vaccines. To detect SARS-CoV-2-neutralizing antibodies, classically, a virus-neutralization test has to be performed at biosafety level 3, considerably limiting the general use of this test. In the present work, a biosafety level 1 pseudotype virus assay based on a propagation-incompetent vesicular stomatitis virus (VSV) has been used to determine the neutralizing antibody titers in convalescent COVID-19 patients. The neutralization titers in serum of two independently analyzed patient cohorts were available within 18 h and correlated well with those obtained with a classical SARS-CoV-2 neutralization test (Pearson correlation coefficients of r = 0.929 and r = 0.939, respectively). Most convalescent COVID-19 patients had only low titers of neutralizing antibodies (ND50 < 320). The sera of convalescent COVID-19 patients also neutralized pseudotype virus displaying the SARS-CoV-1 spike protein on their surface, which is homologous to the SARS-CoV-2 spike protein. In summary, we report a robust virus-neutralization assay, which can be used at low biosafety level 1 to rapidly quantify SARS-CoV-2-neutralizing antibodies in convalescent COVID-19 patients and vaccinated individuals. MDPI 2020-07-15 /pmc/articles/PMC7563800/ /pubmed/32679691 http://dx.doi.org/10.3390/vaccines8030386 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zettl, Ferdinand Meister, Toni Luise Vollmer, Tanja Fischer, Bastian Steinmann, Jörg Krawczyk, Adalbert V’kovski, Philip Todt, Daniel Steinmann, Eike Pfaender, Stephanie Zimmer, Gert Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes |
title | Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes |
title_full | Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes |
title_fullStr | Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes |
title_full_unstemmed | Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes |
title_short | Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes |
title_sort | rapid quantification of sars-cov-2-neutralizing antibodies using propagation-defective vesicular stomatitis virus pseudotypes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563800/ https://www.ncbi.nlm.nih.gov/pubmed/32679691 http://dx.doi.org/10.3390/vaccines8030386 |
work_keys_str_mv | AT zettlferdinand rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes AT meistertoniluise rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes AT vollmertanja rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes AT fischerbastian rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes AT steinmannjorg rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes AT krawczykadalbert rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes AT vkovskiphilip rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes AT todtdaniel rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes AT steinmanneike rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes AT pfaenderstephanie rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes AT zimmergert rapidquantificationofsarscov2neutralizingantibodiesusingpropagationdefectivevesicularstomatitisviruspseudotypes |